Caspase 8 (CASP8) Mouse Monoclonal Antibody [Clone ID: FLICE 1 1-37]

CAT#: AM05285PU-N

Caspase 8 (CASP8) mouse monoclonal antibody, clone FLICE 1 1-37, Purified



Need it in bulk or conjugated?
Get a free quote

CNY 5,937.00


货期*
4周

规格
    • 100 ug

Product images

Specifications

Product Data
Clone Name FLICE 1 1-37
Applications WB
Recommend Dilution Western Blot.
Positive Control: MCF-7 cell lysates.
Reactivity Human
Host Mouse
Clonality Monoclonal
Immunogen Hybridoma produced by the fusion of splenocytes from mice immunized with recombinant human capase-8 protein and mouse myeloma cells.
Specificity This antibody detects proenzyme form of human Caspase-8 by Western blot analysis as well as one of the cleavage products.
Formulation PBS containing 0.08% Sodium Azide as preservative.
State: Purified
State: Liquid (sterile filtered) purified IgG fraction.
Concentration lot specific
Conjugation Unconjugated
Storage Condition Store the antibody at -20°C.
Avoid repeated freezing and thawing.
Gene Name caspase 8
Background Caspases are key effectors of programmed cell death. They are synthesized as inactive proenzymes which are activated by cleavage at a specific aspartate residue to form two subunits. These subunits are normally linked together by a linker which may be involved in the regulation of the different caspases. Caspase-8 is a key enzyme in the apoptosis pathway. Caspase-8 contains two N-terminal region death effector domains which are removed to activate the enzyme along with cleavage into the two subunits. These subunits then for the active protease which is capable of cleaving caspase-3, -6 and -7. These caspases are then capable of cleaving other cellular substrates such as PARP and DFF, which in turn induce apoptosis.
Synonyms CASP-8, CASP8, MCH5, CAP4
Reference Data
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...